Instil Bio
95 hedge funds and large institutions have $577M invested in Instil Bio in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
95
Holding in Top 10
3
Calls
–
Puts
$1K
Top Buyers
| 1 | +$4.43M | |
| 2 | +$2.2M | |
| 3 | +$2.06M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.95M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$1.19M |
Top Sellers
| 1 | -$9.16M | |
| 2 | -$1.64M | |
| 3 | -$1.48M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$968K |
| 5 |
UBS AM
Chicago,
Illinois
|
-$933K |